Novartis backs $176M microbiome biotech fund

John Carroll

has stepped in to back Paris-based Seventure Partners' focused exclusively on the emerging field of the as well as nutrition, bringing its fund to $ 176 million.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS